1. Hypomethylated Rab27b is a progression-associated prognostic biomarker of glioma regulating MMP-9 to promote invasion
   HONGJUN WANG et al, 2015 CrossRef
2. Clustering of patients with intrahepatic cholangiocarcinoma based on serum periostin may be predictive of prognosis
   Chanitra Thuwajit et al, 2017 CrossRef
3. Co-expression of TIMP-1 and its cell surface binding partner CD63 in glioblastomas
   Charlotte Aaberg-Jessen et al, 2018, BMC Cancer CrossRef
4. The landscape of postsurgical recurrence patterns in diffuse low-grade gliomas
   Francois-Xavier Ferracci et al, 2019, Critical Reviews in Oncology/Hematology CrossRef
5. null
   Yingfu Liu et al, 2019 CrossRef
6. Upregulation of miR-181s reverses mesenchymal transition by targeting KPNA4 in glioblastoma
   Hongjun Wang et al, 2015, Sci Rep CrossRef
7. Systematic review of protein biomarkers of invasive behavior in glioblastoma.
   Eli T Sayegh et al, 2014, Mol. Neurobiol. CrossRef
8. Rab27a Was Identified as a Prognostic Biomaker by mRNA Profiling, Correlated with Malignant Progression and Subtype Preference in Gliomas
   Hongjun Wang et al, 2014, PLoS ONE CrossRef
9. Periostin is a new potential prognostic biomarker for glioma
   Buxian Tian et al, 2014, Tumor Biol. CrossRef
10. Targeting adaptive glioblastoma: an overview of proliferation and invasion
    Q. Xie et al, 2014, Neuro-Oncology CrossRef
11. Periostin is a novel therapeutic target that predicts and regulates glioma malignancy
    Andrei M. Mikheev et al, 2015 CrossRef
12. null
    Manny D. Bacolod et al, 2015 CrossRef
13. TWIST1 Heterodimerization with E12 Requires Coordinated Protein Phosphorylation to Regulate Periostin Expression
    Svetlana A. Mikheeva et al, 2019, Cancers CrossRef
14. miR-599 inhibits proliferation and invasion of glioma by targeting periostin
    Tingting Zhang et al, 2017, Biotechnol Lett CrossRef
15. Identification of Periostin as a Potential Biomarker in Gliomas by Database Mining
    Ahmad Faried et al, 2019, World Neurosurgery CrossRef
16. Prognostic Significance of Stromal Periostin Expression in Non-Small Cell Lung Cancer
    Katarzyna Ratajczak-Wielgomas et al, 2020, IJMS CrossRef
17. Stromal POSTN induced by TGF-β1 facilitates the migration and invasion of ovarian cancer
    Huiran Yue et al, 2020, Gynecologic Oncology CrossRef
18. Periostin (POSTN) Regulates Tumor Resistance to Antiangiogenic Therapy in Glioma Models
    Soon Young Park et al, 2016, Mol Cancer Ther CrossRef
19. Role of Periostin Expression in Non-Small Cell Lung Cancer: Periostin Silencing Inhibits the Migration and Invasion of Lung Cancer Cells via Regulation of MMP-2 Expression
    Katarzyna Ratajczak-Wielgomas et al, 2022, IJMS CrossRef
20. Diffusion Weighted Magnetic Resonance Imaging Radiophenotypes and Associated Molecular Pathways in Glioblastoma
    Pascal O. Zinn et al, 2016 CrossRef
21. Molecular mechanisms of drug resistance of glial tumor of brain. Part 2: Proliferation, angiogenesis, metastasis and recurrency
    Alexander N. Chernov et al, 2022, Medical academic journal CrossRef
22. Periostin promotes EMT via inhibition of RIN1-mediated endocytosis of EGFR in gliomas
    Fengqi Zhou et al, 2022, Holist Integ Oncol CrossRef
23. Periostin is Oncogenic and Promotes EMT in Gliomas via Inhibition of RIN1-Mediated Endocytosis of EGFR
    Fengqi Zhou et al, 2021, SSRN Journal CrossRef
24. The Extracellular Matrix in Glioblastomas: A Glance at Its Structural Modifications in Shaping the Tumoral Microenvironment—A Systematic Review
    Salvatore Marino et al, 2023, Cancers CrossRef
25. LIN28B and Let-7 in Diffuse Midline Glioma: A Review
    Truman Knowles et al, 2023, Cancers CrossRef